Leuprolide API is a synthetic gonadotropin-releasing hormone (GnRH) analogue and decapeptide pharmaceutical ingredient used to regulate the hypothalamic-pituitary-gonadal axis. It is structurally related to natural GnRH but contains specific amino-acid substitutions that provide enhanced receptor activity and prolonged biological effects compared with endogenous GnRH.
Leuprolide initially stimulates the pituitary GnRH receptors, producing a transient increase in the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). With continued exposure, however, persistent stimulation results in GnRH-receptor desensitization and downregulation, leading to suppression of LH and FSH secretion and a subsequent reduction in gonadal sex-hormone production.
Leuprolide is commonly encountered in pharmaceutical products as Leuprolide Acetate. It is a peptide API relevant to long-acting injectable and other specialized pharmaceutical formulations. The compound is associated with therapeutic applications involving hormone-dependent conditions, including prostate cancer, endometriosis, uterine fibroids and certain reproductive-health indications.
MEDIOCON INC supplies Leuprolide for applicable pharmaceutical manufacturing, peptide formulation development, analytical research, quality-control testing and bulk API requirements, subject to product availability, applicable regulatory requirements and batch-specific documentation.
| Parameter | Specification |
|---|---|
| Appearance | White to off-white powder |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Leuprolide API Manufacturer & Supplier in India | MEDIOCON INC (CAS 53714-59-9) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Leuprolide API Manufacturer & Supplier in India | MEDIOCON INC is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance